Ligand validation:5XAP

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 5XAP designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5XAP_OLC_A_807	34%	80%	0.185	0.941	0.22	0.6	-	-	1	0	60%	0.6
5XAP_OLC_A_802	22%	52%	0.198	0.848	0.98	0.87	1	-	1	0	80%	0.8
5XAP_OLC_A_806	16%	53%	0.242	0.814	0.9	0.9	1	1	0	0	100%	1
5XAP_OLC_A_803	15%	47%	0.222	0.814	1.15	0.92	1	1	1	0	80%	0.8
5XAP_OLC_A_801	14%	45%	0.252	0.84	1.1	1.08	1	1	1	0	80%	0.8
5XAP_OLC_A_804	9%	80%	0.23	0.847	0.25	0.58	-	-	0	0	32%	0.32
5XAP_OLC_A_805	9%	70%	0.263	0.811	0.24	0.9	-	-	2	0	68%	0.68
5XAN_OLC_B_803	34%	77%	0.181	0.946	0.29	0.6	-	-	0	0	56%	0.56
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	62%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	58%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	55%	0.146	0.929	0.68	1.06	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.